Therefore, the level of hsa_circRNA_103112 in the peripheral blood of a pregnant woman may serve as potential biomarker of fetal DS during non-invasive prenatal screening.
Differential expression profile study and gene function analysis of maternal foetal-derived circRNA for screening for Down syndrome.